EUVIMED · CrossrefJournal
Journal of Clinical Pharmacy and Therapeutics
ISSN 0269-4727 · Hindawi Limited
Latest articles
Dose Optimization Challenges of Colistin Sulfate in ICU Patients With Renal Dysfunction: A Population PK Modeling Approach
Antibiotic Utilization Pattern and Cost Analysis in Burn Patients at a Tertiary Care Hospital: A Retrospective Study
Point Prevalence of Penicillin Allergy Amongst Inpatients at a UK Tertiary Care Hospital
Systemic Cancer Therapy‐Related Adverse Drug Reactions and Associated Clinical Outcomes Among Lymphoma Patients at Kenyatta National Hospital
Adverse Drug Events Associated With Selective Serotonin Reuptake Inhibitor Use During Pregnancy: A Pharmacovigilance Analysis Based on Real‐World Data
Prevalence and Characteristics of Deoxycholate and Liposomal Amphotericin B Adverse Reactions in a Third‐Level Care Hospital: A Retrospective Observational Study
Identification and Validation of the Ferroptosis‐Related Gene SLC2A1 as a Novel Prognostic Biomarker for Osimertinib Resistance in LUAD
Circulating REG4 as an Independent Predictor of Cachexia in Gastric Cancer: Transcriptomic Evidence and Clinical Validation
A Population Pharmacokinetic Model to Assess the Cytochrome P450 2B6 Metabolic Probe Bupropion and Hydroxybupropion in Vitamin D‐Insufficient and ‐Replete Patients With Kidney Disease
Functional Analysis of DPYD Variants Associated With 5‐Fluorouracil‐Based Anticancer Drug Toxicity in Cancer Patients
Artificial Intelligence in Clinical Pharmacy: From Decision Support to Prescription Execution
Potential Contributing Factors for Supratherapeutic and Subtherapeutic Voriconazole Trough Concentrations
Association of Clinical Pharmacist Interventions With Outcomes in Severe Diabetic Foot Infections: A Retrospective Cohort Study
Cardamonin Impairs Glutamine‐Dependent Growth in Ovarian Cancer Cells Through Suppression of mTORC1/Glutaminase
Effectiveness of an Educational Antimicrobial Stewardship Program on Improving Pharmacists’ Knowledge of Antimicrobial Resistance and Stewardship at the Level of the Community
Immune Subtyping of Prostate Adenocarcinoma Reveals Tumor Microenvironment Heterogeneity and Enables a Multigene Recurrence‐Risk Model
Mechanisms of Guanxinning in Myocardial Infarction: An Integrated Approach Using Network Pharmacology, Molecular Docking, and Experimental Validation
Peptic Ulcer Disease Treatment Using Herbal Plants: Harnessing Ethnobotanical Studies for Clinical Application
Optimizing Linezolid Dosing by Renal Function: A Population Pharmacokinetic Study
Establishment of the Drug Exposure Models in the Dosing Environment of Inhaled Preparations and Discussion on Contamination Prevention and Control Measures in the Dosing Procedure
Influence of Glomerular Filtration Rate on Potentially Inappropriate Medications in Older Adults: A Cross‐Sectional Study
HER2‐Targeted Antibody–Drug Conjugates–Associated Interstitial Lung Disease: A Pharmacovigilance Study Based on FDA Adverse Event Reporting System Data
Evaluation of Potentially Inappropriate Medication Use in Patients Aged ≥ 80 Years With Atrial Fibrillation According to STOPP Criteria Version 3 and 2023 Beers Criteria
A Study on the Pharmacokinetic/Pharmacodynamic Profiles of the Novel PPAR Pan‐Agonist Chiglitazar Sodium in Rats With Hypoalbuminemia
Risk of Gastrointestinal Adverse Events in Cancer Patients on Immune Checkpoint Inhibitors: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Advances and Challenges in Model‐Informed Precision Dosing of Antimicrobials for Pediatric Patients
Modified Guizhi Plus Huangqi Decoction Improves Antiphospholipase A2 Receptor Antibody–Induced Podocyte Injury Through Modulating Autophagy‐Related Markers via AMPK/mTOR Pathway
Pharmacist Involvement in Chemotherapy Induced Nausea and Vomiting Management: A Meta‐Analysis
Integrating WNT10B Into a Prognostic Model to Stratify Survival Risk and Immune Phenotype in Colon Cancer
Identifying Cardiac Adverse Event Signals for Natural Products Using Disproportionality Analysis of the FDA Adverse Event Reporting System (FAERS)
Volumes
2026 · 572025 · 502024 · 472023 · 552022 · 3232021 · 2392020 · 2232019 · 1442018 · 1552017 · 1282016 · 1252015 · 1252014 · 1112013 · 992012 · 1322011 · 902010 · 792009 · 942008 · 1422007 · 852006 · 892005 · 922004 · 742003 · 762002 · 682001 · 652000 · 601999 · 641998 · 581997 · 741996 · 731995 · 601994 · 681993 · 681992 · 2091991 · 611990 · 531989 · 611988 · 641987 · 49
EUVIMED